Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam ED50 for Duodenoscopy Insertion in ERCP
NCT04969068Phase 4Unknown
- Sponsor
- Tianjin Nankai Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in Procedural sedation (PS), sponsored by Tianjin Nankai Hospital. Status: unknown.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT04969068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04969068.